{
    "2020-11-23": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：高成长性享有估值溢价 建议持续关注国产创新",
                "features": {
                    "keywords": [
                        "医药生物",
                        "高成长性",
                        "估值溢价",
                        "国产创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "多家知名药企拆分业务",
                "features": {
                    "keywords": [
                        "药企",
                        "拆分业务"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "CRO集体大跌有“幕后”！这些行业潜规则真的存在？",
                "features": {
                    "keywords": [
                        "CRO",
                        "大跌",
                        "幕后",
                        "潜规则"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年度投资策略：以创新应对一切挑战",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "创新",
                        "挑战"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德参股公司Antegenes在香港联交所主板上市，持股比例进一步稀释至0.34%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "Antegenes",
                        "上市",
                        "持股比例",
                        "稀释"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "明日下午3点！医疗器械局部组织反应的生物相容性试验",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "生物相容性",
                        "试验"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}